Deciphering the mechanisms underlying brain alterations and cognitive impairment in congenital myotonic dystrophy
Myotonic dystrophy type 1 (DM1) is a multisystemic and heterogeneous disorder caused by the expansion of CTG repeats in the 3’ UTR of the myotonic dystrophy protein kinase (DMPK) gene. There is a congenital form (CDM1) of the disease characterized by severe hypotonia, respiratory insufficiency as we...
Main Authors: | Thiéry De Serres-Bérard, Marion Pierre, Mohamed Chahine, Jack Puymirat |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-12-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996121002813 |
Similar Items
-
Recent Progress and Challenges in the Development of Antisense Therapies for Myotonic Dystrophy Type 1
by: Thiéry De Serres-Bérard, et al.
Published: (2022-11-01) -
An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I
by: Andrea López-Martínez, et al.
Published: (2020-09-01) -
Development of Therapeutic Approaches for Myotonic Dystrophies Type 1 and Type 2
by: Lubov Timchenko
Published: (2022-09-01) -
Disrupting the Molecular Pathway in Myotonic Dystrophy
by: Xiaomeng Xing, et al.
Published: (2021-12-01) -
A Patient with Myotonic Dystrophy Type 1 Presenting as Parkinsonism
by: Ji-Hyun Choi, et al.
Published: (2018-09-01)